Evidence map›Paper›PMID 25231982›Full record

ArticleThe Journal of biological chemistry2014

Crystal structure of a lipoxygenase in complex with substrate: the arachidonic acid-binding site of 8R-lipoxygenase.

David B Neau, Gunes Bender, William E Boeglin, Sue G Bartlett, Alan R Brash, Marcia E Newcomer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Activation and execution of lipoxygenase catalysis.Redox biochemistry and chemistry · 2026
    Article
  3. Review
  4. Article
  5. Murine Alox8 versus the human ALOX15B ortholog: differences and similarities.Pflugers Archiv : European journal of physiology · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Biochemistry · 2023
    Article
  11. Article
  12. Integracides: Tetracyclic Triterpenoids fromLife (Basel, Switzerland) · 2022
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

David B NeauDepartment of Chemistry and Chemical Biology, Cornell University, Northeastern Collaborative Access Team, Argonne National Laboratory, Argonne, Illinois 60439, and.
Gunes BenderDepartment of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803.
William E BoeglinDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Sue G BartlettDepartment of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803.
Alan R BrashDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.
Marcia E NewcomerDepartment of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana 70803,. Electronic address: newcomer@lsu.edu.
Louisiana State University · USVanderbilt University · USArgonne National Laboratory · US

Funding

THE PHARMACOLOGY OF INHIBITORS OF HEME PROTEIN-CATALYZED LIPID PEROXIDATIONP50GM015431 · NIGMS · VANDERBILT UNIVERSITY · PI MORROW, JASON D. · 1985 to 2010
$15.0M
Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
Therapeutic Modulation of Endothelial Cell TetrahydrobiopterinP01GM015431 · NIGMS · VANDERBILT UNIVERSITY · PI MARNETT, LAWRENCE J. · 2011 to 2015
$9.5M
The Structural Basis for Control of 5-Lipoxgenease ActivityR01HL107887 · NHLBI · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI NEWCOMER, MARCIA E. · 2011 to 2014
$1.4M
NHLBI NIH HHS HL R01 107887NIGMS NIH HHS GM 15431NIGMS NIH HHS P01 GM015431NIGMS NIH HHS P41 GM103403NIGMS NIH HHS P50 GM015431
6 · The paper itself

Abstract

Lipoxygenases (LOX) play critical roles in mammalian biology in the generation of potent lipid mediators of the inflammatory response; consequently, they are targets for the development of isoform-specific inhibitors. The regio- and stereo-specificity of the oxygenation of polyunsaturated fatty acids by the enzymes is understood in terms of the chemistry, but structural observation of the enzyme-substrate interactions is lacking. Although several LOX crystal structures are available, heretofore the rapid oxygenation of bound substrate has precluded capture of the enzyme-substrate complex, leaving a gap between chemical and structural insights. In this report, we describe the 2.0 Å resolution structure of 8R-LOX in complex with arachidonic acid obtained under anaerobic conditions. Subtle rearrangements, primarily in the side chains of three amino acids, allow binding of arachidonic acid in a catalytically competent conformation. Accompanying experimental work supports a model in which both substrate tethering and cavity depth contribute to positioning the appropriate carbon at the catalytic machinery.

Indexed as

AnimalsArachidonate LipoxygenasesArachidonic AcidBinding SitesCatalysisCrystallography, X-RayHumansInflammationIronLipidsModels, MolecularMutagenesisMutationOxygenProtein BindingProtein Conformationarachidonate 8-lipoxygenaseArachidonate LipoxygenasesArachidonic AcidIronLipidsOxygenArachidonic Acid (AA) (ARA)Eicosanoid BiosynthesisLipid SignalingLipoxygenase PathwayProtein StructureX-ray Crystallography

Identifiers

PMID25231982
PMCPMC4231669
OpenAlexW2043980528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.